4.7 Article

Fluorescence sensing strategy based on aptamer recognition and mismatched catalytic hairpin assembly for highly sensitive detection of alpha-fetoprotein

Journal

ANALYTICA CHIMICA ACTA
Volume 1141, Issue -, Pages 21-27

Publisher

ELSEVIER
DOI: 10.1016/j.aca.2020.10.030

Keywords

Aptamer; Mismatched catalytic hairpin assembly; Alpha-fetoprotein; Fluorescence detection; Hepatocellular carcinoma

Funding

  1. new development project of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine [201905]

Ask authors/readers for more resources

The study introduces a fluorescence detection strategy based on aptamer recognition and mismatched catalytic hairpin assembly for highly sensitive detection of AFP, which has a wide detection range and high anti-interference ability.
At present, alpha fetoprotein (AFP) is mainly used as a serum marker of primary Hepatocellular carcinoma. A simple, enzyme-free sensing strategy is introduced for highly sensitive fluorescence detection of AFP. This detection strategy is based on aptamer recognition and mismatched catalytic hairpin assembly (MCHA). At first, Trigger is locked by aptamer before the introduction of AFP in this aptamer-MCHA system. The aptamer preferentially combines with AFP via powerful attraction in the presence of AFP. This results in the release of trigger and initiation of MCHA cycle, thus forming the H1 and H2 double chain complexes (denoted as H1@H2). Finally, H1@H2 and double chain structure containing fluorophore and its quenched group-BHQ1 (denoted as F@Q) initiated displacement reaction, which caused double chain separation and fluorescence recovery. This assay produces a wide detection range, which is from 0.1 ng mL(-1) to 10 mu g mL(-1) and the limit of detection as 0.033 ng mL(-1). The whole detection process was performed at 37 degrees C for 60 min. In addition, this assay had high anti-interference ability and could be used to detect AFP in clinical serum. This novel AFP detection strategy is able to screen of Hepatocellular carcinoma. (C) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available